Verslaving

, Volume 10, Issue 1, pp 55–67 | Cite as

Nicotine: farmacologische en toxicologische aspecten

Middelen
  • 653 Downloads

Dat roken een belangrijke risicofactor is voor morbiditeit en mortaliteit kan als bekend worden verondersteld. Toch rookt ongeveer een kwart van de volwassen Nederlanders, want roken is een zeer verslavende gewoonte. Dat hoge verslavingspotentieel kan voor een substantieel deel worden toegeschreven aan de stof nicotine. Nicotine is niet de enige stof in tabak: in tabaksrook zijn zo’n vierduizend chemische verbindingen geïdentificeerd, waaronder vele stoffen met giftige en carcinogene werking.

Literatuur

  1. Benowitz, N.L. & Gourlay S.G. (1997). Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. Journal of the American College of Cardiology, 29, 1422–1431.PubMedCrossRefGoogle Scholar
  2. Benowitz, N.L. (2003). Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Progress in Cardiovascular Diseases, 46, 91–111.PubMedCrossRefGoogle Scholar
  3. Benowitz, N.L. (2009). Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual Reviews in Pharmacology and Toxicology, 49, 57–71.CrossRefGoogle Scholar
  4. Benowitz, N.L. (2010). Nicotine addiction. New England Journal of Medicine, 362, 2295–2303.PubMedCentralPubMedCrossRefGoogle Scholar
  5. Cohen, G., Roux, J.C., Grailhe, R., Malcolm, G., Changeux, J.P. & Lagercrantz, H. (2005). Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function. Proceedings of the National Acadademy of Science USA, 102, 3817–3821.Google Scholar
  6. Cooke, J.P. & Bitterman, H. (2004). Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Annals of Medicine, 36, 33–40.PubMedCrossRefGoogle Scholar
  7. Eliasson, B. (2003). Cigarette smoking and diabetes. Progress in Cardiovascular Disease, 45, 405–413.CrossRefGoogle Scholar
  8. Foulds, J., Stapleton, J., Swettenham, J., Bell, N., McSorley, K. & Russell, M.A. (1996). Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl), 127, 31–38.CrossRefGoogle Scholar
  9. Foulds, J., Stapleton, J.A., Bell, N., Swettenham, J., Jarvis, M.J. & Russell, M.A. (1997). Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug and Alcohol Dependence, 14, 105–115.CrossRefGoogle Scholar
  10. Harvey, D.M., Yasar, S., Heishman, S.J., Panlilio, L.V., Henningfield, J.E. & Goldberg, S.R. (2004). Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl), 175, 134–142.CrossRefGoogle Scholar
  11. Hecht, S.S. (1999). Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute, 21, 1194–1210.CrossRefGoogle Scholar
  12. Henley, S.J., Connell, C.J., Richter, P., Husten, C., Pechacek, T., e.a. 2007. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tobacco Control, 16, 22–28.PubMedCentralPubMedCrossRefGoogle Scholar
  13. Hoffmann, D. & Hoffmann, I. (1997). The changing cigarette, 1950-1995. Journal of Toxicology and Environmental Health, 50, 307–364.PubMedCrossRefGoogle Scholar
  14. Joseph, A.M., Norman, S.M., Ferry, L.H., Prochazka, A.V., Westman, E.C., e.a. (1996). The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine, 335, 1792–1798.PubMedCrossRefGoogle Scholar
  15. Kalman, D. (2002). The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nicotine and Tobacco Research, 4, 25–70.PubMedCrossRefGoogle Scholar
  16. Luo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H.O., e.a. (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet, 369, 2015–2020.PubMedCrossRefGoogle Scholar
  17. Malizia, E., Andreucci, G., Alfani, F., Smeriglio, M. & Nicholai, P. (1983). Acute intoxication with nicotine alkaloids and cannabinoids in children from ingestion of cigarettes. Human Toxicology, 2, 315–316.PubMedCrossRefGoogle Scholar
  18. Mayer, B. (2014). How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Archives in Toxicology, 88, 5–7.CrossRefGoogle Scholar
  19. Murray, R.P., Bailey, W.C., Daniels, K., Bjornson, W.M., Kurnow, K., Connett, J.E., Nides, M.A. & Kiley, J.P. (1996). Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest, 109, 438–445.PubMedCrossRefGoogle Scholar
  20. National Institute for Occupational Safetv and Health (2000). Registry of toxic effects of chemical substances, NIOSH, Cincinnati. (CD-ROM version.) Denver: Micromedex.Google Scholar
  21. Pidoplichko, V.I., DeBiasi, M., Williams, J.T. & Dani, J.A. (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 27, 401–404.Google Scholar
  22. Puranik, R. & Celermajer, D.S. (2003). Smoking and endothelial function. Progress in Cardiovascular Disease, 45, 443–458.CrossRefGoogle Scholar
  23. Sherwood, N. (1993). Effects of nicotine on human performance. Human Psychopharmacology, 8, 155–184.CrossRefGoogle Scholar
  24. Spindel, E.R. (2009). Is nicotine the estrogen of lung cancer? American Journal of Respiratory Critical Care Medicine, 15, 1081–1082.CrossRefGoogle Scholar
  25. Tyndale, R.F. & Sellers, E.M. (2002). Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Therapeutic Drug Monitoring, 24, 163–171.PubMedCrossRefGoogle Scholar
  26. Vleeming, W., Schenk, E. & Opperhuizen, A. (2005). Van tabakszaad naar tabaksrook. In K. Knol, C. Hilvering, D.J.Th. Wagener & M.C. Willemsen (red.), Tabaksgebruik: gevolgen en bestrijding (pp. 27–41). Utrecht: Lemma.Google Scholar
  27. Warren, G.W. & Singh, A.K. (2013). Nicotine and lung cancer. Journal of Carcinogenesis, 31, 1.CrossRefGoogle Scholar
  28. Wennberg, P., Eliasson, M., Hallmans, G., Johansson, L., Boman, K. & Jansson, J.H. (2007). The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. Journal of Internal Medicine, 262, 360–367.PubMedCrossRefGoogle Scholar
  29. Zeidler, R., Albermann, K. & Lang, S. (2007). Nicotine and apoptosis. Apoptosis, 12, 1927–1943.PubMedCrossRefGoogle Scholar

Copyright information

© Bohn, Stafleu van Loghum 2014

Authors and Affiliations

  1. 1.faculteit Management, Science en TechnologieOpen UniversiteitUtrechtThe Netherlands
  2. 2.Nationaal Expertisecentrum TabaksontmoedigingTrimbosinstituutUtrechtThe Netherlands

Personalised recommendations